[Role and clinical significance of coagulation and inflammatory factors in moderate and severe ovarian endometriosis].

Lin Q, Qiuyu Lin, Q Lin, Shouqin Ding, Ding SJ, S J Ding, Zhu TH, Tao Zhu, T H Zhu, Li TT, T T Li, Xinming Huang, Huang XF, X F Huang, X M Zhang, Xiaofei Zhang, Zhang XM
Zhonghua fu chan ke za zhi · 2018 · vol. 53(3) , pp. 167–171 · doi:10.3760/cma.j.issn.0529-567x.2018.03.005 · PMID:29609230 · W2980455498
article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This study investigated the role and clinical significance of coagulation and inflammatory factors in moderate and severe ovarian endometriosis, finding they may contribute to its pathogenesis and aid in diagnosis and treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The abnormality of coagulation and inflammatory factors may be involved in the pathogenesis of moderate and severe ovarian endometriosis, and the detection of coagulation and inflammatory factors may be have important clinical significance for the diagnosis and treatment of moderate and severe ovarian endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Biomarkers, Tumor Blood Coagulation Endometriosis Fibrin Fibrinogen Degradation Products Fibrinogen Prothrombin Time CA-125 Antigen Female Fibrin Fibrinogen Degradation Products Fibrin Fibrinogen Degradation Products Fibrinogen Fibrinogen Humans Lymphocytes Neutrophils Ovarian Cysts Ovarian Neoplasms Retrospective Studies

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (5)

Source provenance

europepmc
last seen: 2026-07-27T06:15:28.040536+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:19:55.107525+00:00
License: CC0 · commercial use OK